Dr Jonathan Edward Patrick, MD | |
110 Irving St Nw, Na-1101, Washington, DC 20010-3017 | |
(202) 877-7777 | |
Not Available |
Full Name | Dr Jonathan Edward Patrick |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 23 Years |
Location | 110 Irving St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821027475 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD034870 (District Of Columbia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Washington Hospital Center | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Heart Institute Llc | 5698932960 | 171 |
News Archive
Pharmaceutical Strategies Group (PSG), the nation's largest independent pharmacy benefit consulting firm, released today the results of a national survey of companies focused on their views of proposed healthcare reform legislation.
Three Kaiser Permanente Colorado researchers have been named co-recipients of the prestigious Drug Therapy Research Literature Award, an award presented annually by the American Society of Health-System Pharmacists Foundation.
Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.
› Verified 2 days ago
Entity Name | Medstar Heart Institute Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528345378 PECOS PAC ID: 5698932960 Enrollment ID: O20120130000515 |
News Archive
Pharmaceutical Strategies Group (PSG), the nation's largest independent pharmacy benefit consulting firm, released today the results of a national survey of companies focused on their views of proposed healthcare reform legislation.
Three Kaiser Permanente Colorado researchers have been named co-recipients of the prestigious Drug Therapy Research Literature Award, an award presented annually by the American Society of Health-System Pharmacists Foundation.
Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jonathan Edward Patrick, MD 8717 Susanna Ln, Chevy Chase, MD 20815-4713 Ph: (202) 251-6067 | Dr Jonathan Edward Patrick, MD 110 Irving St Nw, Na-1101, Washington, DC 20010-3017 Ph: (202) 877-7777 |
News Archive
Pharmaceutical Strategies Group (PSG), the nation's largest independent pharmacy benefit consulting firm, released today the results of a national survey of companies focused on their views of proposed healthcare reform legislation.
Three Kaiser Permanente Colorado researchers have been named co-recipients of the prestigious Drug Therapy Research Literature Award, an award presented annually by the American Society of Health-System Pharmacists Foundation.
Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.
› Verified 2 days ago
Dr. Adefolaju Oketokun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |